Precision Biosciences, Inc. · NASDAQ:DTIL

Matthew Smith reported a 9.40% stake in Precision Biosciences, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

Matthew Smith reported a 9.40% stake in Precision Biosciences, Inc., 1,119,311 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
9.40%
Shares
1,119,311
Intent
Passive
What changed
Stake changed
Filed together
5 holders

The filing in full

HolderStakeShares
Readout Capital, LP9.30%1,106,437
Readout Capital GP, LLC9.30%1,106,437
ROC Holdings SPV II, LP7.60%906,437
Readout Holdings GP, LLC7.60%906,437
Matthew Smith9.40%1,119,311

Source

View original at SEC

Related